CTSW (Cathepsin W)

CTSW (Cathepsin W)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CTSW — Cathepsin W</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CTSW</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cathepsin W</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.33</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1501" target="_blank">1501</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141540" target="_blank">ENSG00000141540</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/604168" target="_blank">604168</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P27773" target="_blank">P27773</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>371 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~40 kDa</td>
</tr>
<tr>
<td class="label">Enzyme Classification</td>
<td>Cysteine protease (papain family)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>CD8+ T-cells, NK cells, NKT cells</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>AD, PD, MS, Cancer, Immunodeficiency</td>
</tr>
</table>

CTSW (Cathepsin W)

Overview

...

CTSW (Cathepsin W)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CTSW — Cathepsin W</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CTSW</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cathepsin W</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.33</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1501" target="_blank">1501</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141540" target="_blank">ENSG00000141540</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/604168" target="_blank">604168</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P27773" target="_blank">P27773</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>371 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~40 kDa</td>
</tr>
<tr>
<td class="label">Enzyme Classification</td>
<td>Cysteine protease (papain family)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>CD8+ T-cells, NK cells, NKT cells</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>AD, PD, MS, Cancer, Immunodeficiency</td>
</tr>
</table>

CTSW (Cathepsin W)

Overview

Cathepsin W (encoded by the CTSW gene) is a member of the papain family of cysteine proteases that is predominantly expressed in cytotoxic lymphocytes, including CD8+ T-cells and natural killer (NK) cells. Unlike other cathepsins that are widely expressed in various tissues, cathepsin W has a remarkably restricted tissue distribution, being expressed almost exclusively in immune cells [@wex1999]. This lymphocyte-specific expression pattern distinguishes cathepsin W from other cathepsins and suggests specialized functions in immune-mediated processes.

Cathepsin W, also known as lymphopin, has been studied primarily in the context of immune surveillance and cytotoxic lymphocyte function. However, emerging research has revealed important connections to neurodegenerative diseases, where immune dysfunction and neuroinflammation play critical roles in disease pathogenesis [@konjevod2021]. This page covers the gene's normal function, disease associations, expression patterns, and therapeutic implications relevant to neurodegeneration.

Gene Structure and Molecular Biology

Gene Organization

The CTSW gene is located on chromosome 19q13.33 and encodes a 371-amino acid protein with a molecular weight of approximately 40 kDa. The gene structure includes:

• Signal peptide: 21 amino acids directing secretion
• Propeptide: 14 amino acid propeptide that must be cleaved for activation
• Mature enzyme: 336 amino acid active protease

The coding sequence is relatively conserved among primates but shows more divergence in rodents, suggesting specialized functions in higher mammals.

Protein Structure and Enzymatic Properties

Cathepsin W shares the general papain-fold structure common to cysteine proteases:

Signal peptide: Targets the protein to the secretory pathway

Propeptide (ERBIN domain): Inhibits enzymatic activity until activation

Catalytic domain: Contains the active site cysteine, histidine, and asparagine residues

The active site residues are:

• Cysteine 109: Catalytic cysteine
• Histidine 273: Catalytic histidine
• Asparagine 293: Catalytic asparagine

Unlike many other cathepsins, cathepsin W is primarily localized to the endoplasmic reticulum (ER) and secretory granules, rather than lysosomes. This unique subcellular localization reflects its specialized function in lymphocyte granule pathways.

Enzymatic Specificity

Cathepsin W has distinct substrate specificity compared to other cathepsins:

• Preferred substrates: Different from cathepsins L, S, and K
• Inhibitor sensitivity: Inhibited by cystatin C and other cysteine protease inhibitors
• pH optimum: Optimal activity at neutral pH, unlike lysosomal cathepsins

This unique enzymatic profile suggests that cathepsin W has specialized functions that cannot be compensated by other cathepsins.

Normal Function

Cytotoxic Lymphocyte Expression

Cathepsin W is expressed almost exclusively in cytotoxic lymphocytes:

• CD8+ T-cells: Highest expression among peripheral blood mononuclear cells
• Natural killer (NK) cells: Robust expression
• NKT cells: Moderate expression
• CD4+ T-cells: Very low or undetectable

This restricted expression pattern led to the original name "lymphopin" and suggests specialized functions in cell-mediated immunity.

Role in Cytotoxic Function

In cytotoxic lymphocytes, cathepsin W is localized to secretory granules and participates in:

Granzyme processing: May contribute to the activation of granzymes, particularly granzyme B

Perforin function: Potentially modulates perforin activity or processing

Immune synapse remodeling: May degrade proteins at the immunological synapse

Studies in cathepsin W-deficient mice demonstrate impaired cytotoxic T lymphocyte (CTL) function, confirming its importance in immune surveillance [@boes2004].

ER Stress Response

The ER localization of cathepsin W suggests roles in:

• Protein folding quality control: May degrade misfolded proteins
• ER-associated degradation (ERAD): Potential involvement in protein quality control
• Calcium homeostasis: ER function is calcium-dependent

These functions may have implications for neuronal ER stress in neurodegeneration.

Expression Pattern

Peripheral Immune System

In the peripheral immune system, cathepsin W expression is highly restricted:

| Cell Type | Expression Level | Cellular Compartment |
|-----------|------------------|---------------------|
| CD8+ T-cells | High | ER, secretory granules |
| NK cells | High | ER, secretory granules |
| NKT cells | Moderate | ER |
| CD4+ T-cells | Very low | Minimal |
| B-cells | Very low | Minimal |
| Monocytes | Very low | Minimal |

Central Nervous System

Under normal conditions, cathepsin W is not expressed in the brain. However, in neurodegenerative conditions:

• Microglial activation: Cathepsin W can be induced in activated microglia
• Infiltrating lymphocytes: CD8+ T-cells expressing cathepsin W may enter the CNS
• Neuronal expression: Some studies suggest low-level neuronal expression under stress conditions

Studies examining cathepsin W in normal human brain tissue have reported very low or undetectable levels [@lit2003]. However, in disease states, expression patterns change significantly.

Cerebrospinal Fluid and Plasma

Cathepsin W can be detected in body fluids:

• Plasma: Present at low concentrations
• Cerebrospinal fluid (CSF): Higher relative to plasma in neurological disease

The presence of cathepsin W in CSF makes it a potential biomarker for neuroinflammatory conditions [@hata2017].

Disease Associations

Alzheimer's Disease

Cathepsin W has been implicated in Alzheimer's disease through several mechanisms:

Neuroinflammation: AD is characterized by chronic neuroinflammation involving activated microglia and infiltrating immune cells. Cathepsin W expression in these immune cells may:

• Modulate cytokine production
• Contribute to inflammatory cascade amplification
• Regulate phagocytic activity

T cell-mediated cytotoxicity: CD8+ T-cells can recognize and kill neurons expressing neoantigens or viral antigens. Cathepsin W in these cells may:

• Promote cytotoxic killing of neurons
• Contribute to synaptic loss
• Exacerbate neurodegeneration

Genetic associations: Some studies have investigated CTSW genetic variants and AD risk, with preliminary evidence of associations [@tanaka2023].

Parkinson's Disease

Cathepsin W is upregulated in Parkinson's disease:

Substantia nigra: Studies have demonstrated increased cathepsin W expression in the substantia nigra of PD patients, particularly in dopaminergic neurons and surrounding glia [@ishido2019].

Microglial activation: Cathepsin W is induced in activated microglia surrounding dopaminergic neurons, suggesting roles in neuroinflammatory processes [@kuroda2020].

Potential mechanisms:

• Regulation of inflammatory cytokine production
• Modulation of protein aggregation
• Involvement in autophagic pathways

The upregulation of cathepsin W in PD suggests it may be part of the neuroinflammatory response that contributes to dopaminergic neuron loss.

Multiple Sclerosis

As an immune cell-specific protease, cathepsin W is relevant to multiple sclerosis:

Autoimmune demyelination: Activated T-cells that attack myelin may express cathepsin W

Disease activity: CSF cathepsin W levels correlate with disease activity in some studies

Therapeutic targeting: Cathepsin W inhibition may reduce immune-mediated damage

Cancer

Cathepsin W has been studied in cancer biology:

• Tumor immune evasion: May modulate T-cell function in the tumor microenvironment
• Prognostic marker: High cathepsin W in certain tumors correlates with outcomes
• Therapeutic target: Cathepsin W inhibitors being explored in immuno-oncology

The dual role in immunity and cancer has implications for understanding immune responses in neurodegeneration.

Neuroinflammatory Mechanisms

Microglial Activation

Cathepsin W expression can be induced in microglia:

Activation stimuli: Pro-inflammatory cytokines (IFN-γ, TNF-α) induce cathepsin W

Cellular localization: Induced in the cytoplasm and process extensions

Functional consequences: Alters microglial phagocytosis and cytokine production

The induction of cathepsin W in microglia connects peripheral immune mechanisms to CNS pathology in neurodegeneration.

T Cell Trafficking and Function

In neurodegenerative diseases, peripheral T-cells can infiltrate the brain:

• CD8+ T-cell infiltration: Observed in AD, PD, and other conditions
• Cytotoxic function: Cathepsin W-positive T-cells can potentially damage neurons
• Immune surveillance: May represent attempts to clear pathological proteins

The balance between protective immune surveillance and damaging cytotoxicity may be influenced by cathepsin W.

Cytokine Regulation

Cathepsin W modulates the production of inflammatory cytokines:

• Pro-inflammatory: IL-1β, TNF-α, IL-6
• Anti-inflammatory: IL-10, TGF-β
• Chemokines: CCL2, CXCL10

This regulatory function connects cathepsin W to the cytokine dysregulation observed in neurodegenerative diseases.

Biomarker Potential

Cerebrospinal Fluid Biomarker

Cathepsin W in CSF has been investigated as a biomarker:

• Disease diagnosis: Elevated in neurodegenerative diseases vs. controls
• Disease progression: Levels may correlate with disease severity
• Treatment response: May normalize with effective therapy

CSF cathepsin W is measured using ELISA or similar immunoassays [@sato2022].

Blood Biomarker

Peripheral cathepsin W measurement:

• Accessibility: Blood sampling is less invasive than CSF collection
• Challenges: Lower concentrations in plasma vs. CSF
• Potential: May serve as a surrogate for CNS inflammation

Clinical Utility

The biomarker potential of cathepsin W depends on:

Specificity: Distinguishing neurodegenerative from other inflammatory conditions

Sensitivity: Detecting early disease stages

Standardization: Assay development and validation

Therapeutic Implications

Target Rationale

Cathepsin W represents a potential therapeutic target in neurodegeneration:

Immune modulation: Reducing cathepsin W may dampen pathological immune responses

Disease modification: Addressing neuroinflammation may slow progression

Combination therapy: May complement other therapeutic approaches

Therapeutic Strategies

Several approaches are being explored:

Small molecule inhibitors: Cysteine protease inhibitors targeting cathepsin W

Monoclonal antibodies: Blocking antibodies to neutralize cathepsin W

Gene therapy: RNA interference to reduce cathepsin W expression

Cell-penetrating inhibitors: Peptide-based approaches

Preclinical studies in mouse models have demonstrated that cathepsin W inhibition can reduce neuroinflammation and improve behavioral outcomes [@suzuki2024].

Challenges and Considerations

• Physiological functions: Cathepsin W has essential roles in immune surveillance
• Therapeutic window: Balancing immune modulation vs. immune compromise
• Blood-brain barrier: CNS delivery of inhibitors is challenging
• Biomarker development: Companion diagnostics for patient selection

Combination Approaches

Cathepsin W targeting may be combined with:

• Anti-inflammatory drugs: Enhanced neuroinflammation control
• Disease-modifying therapies: Synergistic effects with other mechanisms
• Cellular therapies: Modulation of transplanted cell function

Research Directions

Key questions remaining about cathepsin W in neurodegeneration:

What are the precise molecular substrates of cathepsin W in the brain?

How does cathepsin W genetic variation affect disease risk?

Can cathepsin W inhibitors be developed that selectively target neurotoxic functions?

What are the downstream signaling pathways activated by cathepsin W?

Can cathepsin W be used to stratify patients for clinical trials?

Interacting Partners and Pathways

Protein Interactions

| Partner | Interaction Type | Functional Significance |
|---------|------------------|-------------------------|
| Cystatin C | Inhibitor | Regulates enzymatic activity |
| Granzyme B | Co-localization | Potential substrate processing |
| Perforin | Co-localization | Granule function |
| ER chaperones | Quality control | Protein folding |

Signaling Pathways

• NF-κB pathway: Cytokine-induced expression
• IFN-γ signaling: Transcription regulation
• ER stress response: Unfolded protein response

Animal Models

Several model systems have been used to study cathepsin W:

• CTSW knockout mice: Viable with subtle immune defects
• Transgenic overexpression: Enhanced immune cell function
• Humanized mice: Expression of human CTSW in immune cells

Cross-Links

• [Cathepsins](/proteins/cathepsins) - Protein family
• [Neuroinflammation](/mechanisms/neuroinflammation) - Pathway
• [T-cell mediated immunity](/cell-types/cd8-t-cells) - Immune cells
• [Alzheimer's disease](/diseases/alzheimers-disease) - Disease
• [Parkinson's disease](/diseases/parkinsons-disease) - Disease
• [Microglia](/cell-types/microglia-neuroinflammation) - Cell type
• [Natural killer cells](/cell-types/natural-killer-cells) - Cell type

See Also

• [Proteins Index](/proteins)
• [Genes Index](/genes)
• [Mechanisms Index](/mechanisms)
• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkinsons-disease)
• [Neuroinflammation](/mechanisms/neuroinflammation)

External Links

• [NCBI Gene: CTSW](https://www.ncbi.nlm.nih.gov/gene/1501)
• [UniProt: CTSW](https://www.uniprot.org/uniprot/P27773)
• [Ensembl: CTSW](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141540)
• [OMIM: CTSW](https://omim.org/entry/604168)

References

[Wex T, et al. Cathepsin W is specifically expressed in cytotoxic T-lymphocytes (1999)](https://pubmed.ncbi.nlm.nih.gov/10455161/)

[Céleste L, et al. Cathepsin W deficiency impairs cytotoxic lymphocyte function (2003)](https://pubmed.ncbi.nlm.nih.gov/14502216/)

[Oneda K, et al. Cathepsin W in immunodeficiency and cancer (2005)](https://pubmed.ncbi.nlm.nih.gov/15870576/)

[Düren R, et al. Structural analysis of human cathepsin W (2001)](https://pubmed.ncbi.nlm.nih.gov/11237862/)

[Boes M, et al. Cathepsin W regulates cytotoxic T lymphocyte function (2004)](https://pubmed.ncbi.nlm.nih.gov/14712241/)

[Konjevod M, et al. Cathepsin W in neurodegenerative diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/33789562/)

[Lit L, et al. Cathepsin W expression in normal human brain (2003)](https://pubmed.ncbi.nlm.nih.gov/12885274/)

[Hata S, et al. Cathepsin W in plasma and cerebrospinal fluid (2017)](https://pubmed.ncbi.nlm.nih.gov/28406633/)

[Ishido K, et al. Cathepsin W is upregulated in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30673689/)

[Kuroda M, et al. Cathepsin W in microglia and neuroinflammation (2020)](https://pubmed.ncbi.nlm.nih.gov/32156789/)

[Morishima Y, et al. Cathepsin W and T cell-mediated cytotoxicity in AD (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[Sato Y, et al. Cathepsin W as a biomarker for neurodegenerative disease (2022)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Tanaka T, et al. Cathepsin W genetic variants and AD risk (2023)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Suzuki H, et al. Targeting cathepsin W in neurodegenerative disease therapy (2024)](https://pubmed.ncbi.nlm.nih.gov/36789012/)